塞力医疗跌2.04%，成交额1.72亿元，主力资金净流出1764.15万元

Core Viewpoint - The stock of Sely Medical has experienced a significant increase of 198.75% this year, but has recently shown a decline in trading performance, with a drop of 3.66% over the last five trading days and 21.39% over the last 60 days [1]. Group 1: Stock Performance - As of December 26, Sely Medical's stock price is 21.57 CNY per share, with a market capitalization of 4.534 billion CNY [1]. - The company has seen a net outflow of 17.64 million CNY in principal funds, with large orders buying 11.94 million CNY and selling 30.74 million CNY [1]. - Sely Medical has appeared on the trading leaderboard 37 times this year, with the most recent appearance on August 26, where it recorded a net purchase of 146 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Sely Medical reported a revenue of 857 million CNY, a year-on-year decrease of 39.64%, and a net profit attributable to shareholders of -87.24 million CNY, down 55.72% year-on-year [2]. - The company has not distributed any dividends in the last three years, with a total payout of 27.07 million CNY since its A-share listing [3]. Group 3: Shareholder Information - As of December 10, the number of shareholders for Sely Medical is 70,400, a decrease of 11.22% from the previous period, with an average of 2,986 circulating shares per person, an increase of 12.64% [2]. - Notable institutional shareholders include Caixin Advantage Industry Rotation Mixed Fund, which increased its holdings by 58.48% to 1.2282 million shares, and new entrants such as GF Healthcare Stock A and others [3].